Association between medication adherence and health-related quality of life of patients with hypertension and dyslipidemia

[1] Ge L(2019)Effects of chronic diseases on health-related quality of life and self-rated health among three adult age groups Nurs Health Sci 21 214-222

[2] Ong R(2008)Health-related quality of life among general practice patients with differing chronic diseases in Germany: cross sectional survey BMC Public Health 8 246-237

[3] Yap CW(2020)The global epidemiology of hypertension Nat Rev Nephrol 16 223-700

[4] Heng BH(2021)Global epidemiology of dyslipidaemias Nat Rev Cardiol 18 689-802

[5] Wang HM(2021)Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension Nat. Rev. Cardiol 18 785-223

[6] Beyer M(2005)Global burden of hypertension: analysis of worldwide data Lancet 365 217-1360

[7] Gensichen J(2002)Selected major risk factors and global and regional burden of disease Lancet 360 1347-1039

[8] Gerlach FM(2021)Prevalence, awareness, treatment and control of hypertension in Greece: EMENO national epidemiological study J Hypertens 39 1034-s148

[9] Mills KT(2017)Epidemiology and management of hyperlipidemia Am J Manag Care 23 S139-193

[10] Stefanescu A(2012)Prevalence and risk distribution of residual dyslipidemia in statin-treated patients in Greece Angiology 63 184-e90

[1] Ge L(2019)Effects of chronic diseases on health-related quality of life and self-rated health among three adult age groups Nurs Health Sci 21 214-222

[2] Ong R(2008)Health-related quality of life among general practice patients with differing chronic diseases in Germany: cross sectional survey BMC Public Health 8 246-237

[3] Yap CW(2020)The global epidemiology of hypertension Nat Rev Nephrol 16 223-700

[4] Heng BH(2021)Global epidemiology of dyslipidaemias Nat Rev Cardiol 18 689-802

[5] Wang HM(2021)Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension Nat. Rev. Cardiol 18 785-223

[6] Beyer M(2005)Global burden of hypertension: analysis of worldwide data Lancet 365 217-1360

[7] Gensichen J(2002)Selected major risk factors and global and regional burden of disease Lancet 360 1347-1039

[8] Gerlach FM(2021)Prevalence, awareness, treatment and control of hypertension in Greece: EMENO national epidemiological study J Hypertens 39 1034-s148

[9] Mills KT(2017)Epidemiology and management of hyperlipidemia Am J Manag Care 23 S139-193

[10] Stefanescu A(2012)Prevalence and risk distribution of residual dyslipidemia in statin-treated patients in Greece Angiology 63 184-e90